{
    "2018-08-06": [
        [
            {
                "time": "2018-07-01",
                "original_text": "Can Mylan Exceed Analystsâ€™ Earnings Estimates in Q2 2018?",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Earnings",
                        "Exceed",
                        "Analysts"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "Can These Biotech Companies Catch Novartis, Gilead In CAR-T?",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Novartis",
                        "Gilead",
                        "CAR-T"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "Does Bausch Face A Reckoning? 5 Key Issues To Look For In Its Earnings",
                "features": {
                    "keywords": [
                        "Bausch",
                        "Reckoning",
                        "Earnings",
                        "Issues"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "Could Mylan Again Report a Sales Decline in Q2 2018?",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Sales",
                        "Decline",
                        "Q2"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "What Analysts Recommend for Mylan before Q2 2018 Earnings",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommend",
                        "Mylan",
                        "Earnings"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "The Zacks Analyst Blog Highlights: Pfizer, Bristol-Myers, Sanofi, Glaxo and Novartis",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Pfizer",
                        "Bristol-Myers",
                        "Sanofi",
                        "Glaxo",
                        "Novartis"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "Why Novartis Stock Gained 11% in July",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Stock",
                        "Gained",
                        "July"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "The Swiss Stock Market Dipped In Directionless Trade",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market",
                        "Dipped",
                        "Directionless",
                        "Trade"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}